Literature DB >> 17685652

Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships.

Peter L Katavic1, Kenneth Lamb, Hernan Navarro, Thomas E Prisinzano.   

Abstract

Flavonoids have been recognized as the active ingredients of many medicinal plant extracts due to interactions with proteins via phenolic groups and low toxicity. Here, we report the investigation of the flavonoid core as a potential new scaffold for the development of opioid receptor ligands. Biological results suggest that stereochemistry of the C2 and C3 positions is important for antagonist activity and selectivity. Our results also suggest that the actions of Hypericum perforatum may be mediated in part by opioid receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17685652      PMCID: PMC2265593          DOI: 10.1021/np070194x

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  43 in total

1.  Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test.

Authors:  V Butterweck; G Jürgenliemk; A Nahrstedt; H Winterhoff
Journal:  Planta Med       Date:  2000-02       Impact factor: 3.352

2.  Bimorphinans as highly selective, potent kappa opioid receptor antagonists.

Authors:  A S Portoghese; A W Lipkowski; A E Takemori
Journal:  J Med Chem       Date:  1987-02       Impact factor: 7.446

3.  N-substituted 4beta-methyl-5-(3-hydroxyphenyl)-7alpha-amidomorphans are potent, selective kappa opioid receptor antagonists.

Authors:  F Ivy Carroll; Matt S Melvin; Michel C Nuckols; S Wayne Mascarella; Hernán A Navarro; James B Thomas
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

Review 4.  Interactions between kappa opioid agonists and cocaine. Preclinical studies.

Authors:  N K Mello; S S Negus
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model.

Authors:  F Ivy Carroll; Louis S Harris; Mario D Aceto
Journal:  Eur J Pharmacol       Date:  2005-10-19       Impact factor: 4.432

6.  (±)-Diinsininone: made nature's way.

Authors:  Carolyn Selenski; Thomas R R Pettus
Journal:  Tetrahedron       Date:  2006-05-29       Impact factor: 2.457

Review 7.  Plant derivatives in the treatment of alcohol dependency.

Authors:  Amir H Rezvani; David H Overstreet; Marina Perfumi; Maurizio Massi
Journal:  Pharmacol Biochem Behav       Date:  2003-06       Impact factor: 3.533

8.  Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist.

Authors:  Ivy Carroll; James B Thomas; Linda A Dykstra; Arthur L Granger; Richard M Allen; James L Howard; Gerald T Pollard; Mario D Aceto; Louis S Harris
Journal:  Eur J Pharmacol       Date:  2004-10-06       Impact factor: 4.432

9.  A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists.

Authors:  S L Olmsted; A E Takemori; P S Portoghese
Journal:  J Med Chem       Date:  1993-01-08       Impact factor: 7.446

10.  In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum.

Authors:  Giuseppina Mattace Raso; Maria Pacilio; Giulia Di Carlo; Emanuela Esposito; Luisa Pinto; Rosaria Meli
Journal:  J Pharm Pharmacol       Date:  2002-10       Impact factor: 3.765

View more
  18 in total

1.  Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish.

Authors:  Sean M Bugel; Robert L Tanguay
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-27       Impact factor: 4.219

2.  Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on delta-opioid receptor stimulation.

Authors:  Mathivadhani Panneerselvam; Yasuo M Tsutsumi; Jacqueline A Bonds; Yousuke T Horikawa; Michelle Saldana; Nancy D Dalton; Brian P Head; Piyush M Patel; David M Roth; Hemal H Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-10       Impact factor: 4.733

3.  Opioidergic mechanisms underlying the actions of Vitex agnus-castus L.

Authors:  Donna E Webster; Ying He; Shao-Nong Chen; Guido F Pauli; Norman R Farnsworth; Zaijie Jim Wang
Journal:  Biochem Pharmacol       Date:  2010-09-18       Impact factor: 5.858

Review 4.  Polyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits.

Authors:  David O Kennedy
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

Review 5.  Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

Authors:  Filipa I Baptista; Ana G Henriques; Artur M S Silva; Jens Wiltfang; Odete A B da Cruz e Silva
Journal:  ACS Chem Neurosci       Date:  2014-01-03       Impact factor: 4.418

6.  5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.

Authors:  Dwight A Williams; Saheem A Zaidi; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2014-02-19       Impact factor: 2.823

Review 7.  Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?

Authors:  Susana Almeida; Marco G Alves; Mário Sousa; Pedro F Oliveira; Branca M Silva
Journal:  Neurotox Res       Date:  2016-01-08       Impact factor: 3.911

Review 8.  Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse.

Authors:  Thomas E Prisinzano
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

9.  Antinociceptive Effect of the Citrus Flavonoid Eriocitrinon Postoperative Pain Conditions.

Authors:  Saad Alghamdi
Journal:  J Pain Res       Date:  2020-04-22       Impact factor: 3.133

10.  The effect of flavanol-rich cocoa on cerebral perfusion in healthy older adults during conscious resting state: a placebo controlled, crossover, acute trial.

Authors:  Daniel J Lamport; Deepa Pal; Christina Moutsiana; David T Field; Claire M Williams; Jeremy P E Spencer; Laurie T Butler
Journal:  Psychopharmacology (Berl)       Date:  2015-06-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.